1. FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling
   Qiji Li et al, 2017, Cancer Letters CrossRef
2. Mitotic quiescence, but not unique “stemness,” marks the phenotype of bone metastasis-initiating cells in prostate cancer
   Ning Wang et al, 2015, The FASEB Journal CrossRef
3. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas
   Osama A Elkashty et al, 2020, Carcinogenesis CrossRef
4. The roles of LSD1-mediated epigenetic modifications in maintaining the pluripotency of bladder cancer stem cells
   Weihua Lan et al, 2013, Medical Hypotheses CrossRef
5. YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells
   XIA SHENG et al, 2015, Molecular Medicine Reports CrossRef
6. MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features
   Xiaoran Li et al, 2016, Oncotarget CrossRef
7. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas
   Hatem O. Kaseb et al, 2016, Experimental Cell Research CrossRef
8. The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells
   Maryam Akbarzadeh et al, 2017, Scientific Reports CrossRef
9. Interactions with Muscle Cells Boost Fusion, Stemness, and Drug Resistance of Prostate Cancer Cells
   Berna Uygur et al, 2019, Molecular Cancer Research CrossRef
10. Assessment of Anti-Prostate Cancer Activity among Four Seaweeds, with Focus on Caulerpa lentillifera J.Agardh
    Guan-James Wu et al, 2024, Foods CrossRef
11. A platform for actively loading cargo RNA to elucidate limiting steps in EV‐mediated delivery
    Michelle E. Hung et al, 2016, Journal of Extracellular Vesicles CrossRef
12. Identification of cancer stem cells derived from U118MG and the involvement of LncRNA-DC and STAT3 in promoting their malignant transformation
    Qingxi Liu et al, 2023, Oncologie CrossRef
13. Phenotypic characteristics of CD133+ EpCAM+ cancer stem-like cells derived from the human hepatoma HepG2 cell line
    Hadeer A. Aglan et al, 2022, Journal of The Arab Society for Medical Research CrossRef
14. An iTEP-salinomycin nanoparticle that specifically and effectively inhibits metastases of 4T1 orthotopic breast tumors
    Peng Zhao et al, 2016, Biomaterials CrossRef
15. Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives
    Tapan Behl et al, 2020, Biomedicines CrossRef
16. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence
    null null et al, 2015, Nature Genetics CrossRef
17. Withaferin A Induces Cell Death Selectively in Androgen-Independent Prostate Cancer Cells but Not in Normal Fibroblast Cells
    Yukihiro Nishikawa et al, 2015, PLOS ONE CrossRef
18. BAZ2A‐mediated repression via H3K14ac‐marked enhancers promotes prostate cancer stem cells
    Rodrigo Peña‐Hernández et al, 2021, EMBO reports CrossRef
19. Molecular insights into withaferin A: A holistic approach to cancer therapy
    Md. Rezaul Islam et al, 2024, Inorganic Chemistry Communications CrossRef
20. Development of a novel mammalian display system for selection of antibodies against membrane proteins
    Nathan Robertson et al, 2020, Journal of Biological Chemistry CrossRef
21. Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer
    Wout Devlies et al, 2021, Cancers CrossRef
22. Investigation of L-carnitine effects on CD44+ cancer stem cells from MDA-MB-231 breast cancer cell line as anti-cancer therapy
    Raheleh Farahzadi et al, 2023, Regenerative Therapy CrossRef